Table 1: Demographic and Baseline Data for Intention-to-Treat Population

Variable Placebo N = 20 HA N = 22
Gender
(males) a
(females) a
5 (25.0%)
15 (75.0%)
5 (22.7 %)
17 (77.3 %)
Ethnic
(Caucasian) a
20 (100.0%) 22 (100.0%)
Age (years) b 68.3 (9.1) 67.5 (8.1)
Body Mass Index (BMI) (Kg/m2) b 34.2 (6.7) 32.7 (4.1)
Years since diagnosis c 11 (11.0) 10.0 (7.0)
Pain WOMAC subscale d 67.6 (60.4-74.8) 62.6 (58.9-66.4)
Stiffness WOMAC subscale d 67.4 (57.4-77.3) 64.2 (53.3-75.0)
Physical function WOMAC subscale d 71.2 (63.5-78.9) 63.2 (55.6-70.7)
Total WOMAC index score d 70.1 (63.2-77.1) 63.1 (56.4-69.9)

a n (%).
b Mean (S.D.).
c Median (interquantilic range).
c Mean (95% CI).